Your browser doesn't support javascript.
loading
Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol.
Meric-Bernstam, F; Brusco, L; Daniels, M; Wathoo, C; Bailey, A M; Strong, L; Shaw, K; Lu, K; Qi, Y; Zhao, H; Lara-Guerra, H; Litton, J; Arun, B; Eterovic, A K; Aytac, U; Routbort, M; Subbiah, V; Janku, F; Davies, M A; Kopetz, S; Mendelsohn, J; Mills, G B; Chen, K.
Afiliación
  • Meric-Bernstam F; Department of Investigational Cancer Therapeutics Department of Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy Department of Surgical Oncology fmeric@mdanderson.org.
  • Brusco L; Department of Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy.
  • Daniels M; Department of Gynecologic Oncology and Reproductive Medicine Program of Clinical Cancer Genetics.
  • Wathoo C; Department of Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy.
  • Bailey AM; Department of Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy.
  • Strong L; Program of Clinical Cancer Genetics.
  • Shaw K; Department of Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy.
  • Lu K; Department of Gynecologic Oncology and Reproductive Medicine Program of Clinical Cancer Genetics.
  • Qi Y; Department of Bioinformatics and Computational Biology.
  • Zhao H; Department of Bioinformatics and Computational Biology.
  • Lara-Guerra H; Department of Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy Department of RedSky/Biomedical Institute of the Americas, El Paso, USA.
  • Litton J; Department of Breast Medical Oncology.
  • Arun B; Department of Breast Medical Oncology Program of Clinical Cancer Genetics.
  • Eterovic AK; Department of Systems Biology.
  • Aytac U; Department of Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy.
  • Routbort M; Department of Hematopathology.
  • Subbiah V; Department of Investigational Cancer Therapeutics.
  • Janku F; Department of Investigational Cancer Therapeutics.
  • Davies MA; Department of Systems Biology Department of Melanoma Medical Oncology.
  • Kopetz S; Department of Gastrointestinal (GI) Medical Oncology, MD Anderson Cancer Center, Houston.
  • Mendelsohn J; Department of Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy Department of Genomic Medicine.
  • Mills GB; Department of Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy Department of Systems Biology.
  • Chen K; Department of Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy Department of Bioinformatics and Computational Biology.
Ann Oncol ; 27(5): 795-800, 2016 05.
Article en En | MEDLINE | ID: mdl-26787237
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mutación de Línea Germinal / Proteínas de Neoplasias / Neoplasias Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mutación de Línea Germinal / Proteínas de Neoplasias / Neoplasias Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido